This pilot study will evaluate the emPath digital platform, a platform designed to improve access to and retention in low-barrier telemedicine for delivery of medication for opioid use disorder (MOUD) among adults with opioid use disorder who engage with community outreach programs in Durham, North Carolina.
Age 18 or older
Screen positive for moderate to high risk opioid use by WHO-ASSIST
Not currently prescribed any form of MOUD
Able to speak and understand English
None
Single group
emPath Intervention
BehavioralCommunity-partnered telemedicine platform providing registration, video visits, messaging, and low-barrier MOUD access.
feasibility, as measured by retention in care
Retention in care is defined by at least one virtual visit conducted before and after the expected 3- or 6-month timepoint from enrollment, whichever later timepoint is available based on the participant's timing of enrollment during the study period.
acceptability
Surveys (intervention acceptability, appropriateness, fidelity) Program participants and outreach staff will complete a 3 and 6-month follow-up assessment (if applicable) including additional validated survey tools for the implementation evaluation: the acceptability of intervention measure (AIM).
appropriateness
Program participants and outreach staff will complete a 3 and 6-month follow-up assessment (if applicable) including additional validated survey tools for the implementation evaluation: the intervention appropriateness measure (IAM)
intervention fidelity
To measure implementation protocol fidelity, staff will complete in a baseline survey and 6-month assessment several items related to their contributions to program activities, roles and responsibilities in relation to the implementation protocol.
Intervention reach, as measured by weekly and monthly rates of participant platform feature engagement (dashboard, messaging, queue, video portal)
Click on the lead sponsor to view all of their trials.
